These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 5026606)

  • 1. [Drug enclosures and drug consumption].
    Springer MP
    Pharm Weekbl; 1972 Apr; 107(16):M227-32. PubMed ID: 5026606
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescription and proscription.
    Ingelfinger FJ; Elia JJ
    N Engl J Med; 1971 Nov; 285(21):1199-201. PubMed ID: 5096644
    [No Abstract]   [Full Text] [Related]  

  • 3. Techniques for selecting, evaluating & compacting the drug literature. Pharmaceutical consultant.
    De Haen P
    Am J Hosp Pharm; 1966 Feb; 23(2):71-6. PubMed ID: 5907115
    [No Abstract]   [Full Text] [Related]  

  • 4. [Drug information: what for and how].
    Måseide T
    Tidsskr Nor Laegeforen; 1970 Apr; 90(7):692-5. PubMed ID: 5460435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Influence of retail prices on drug consumption].
    Federmann J; Cechová M; Partis J
    Cesk Zdrav; 1972 Nov; 20(11):458-67. PubMed ID: 4653150
    [No Abstract]   [Full Text] [Related]  

  • 6. Michigan regional drug information network. 3. Utilization of information received from a drug information center.
    Pearson RE; Schmalgemeier W; Bendall M; Mehta P
    Am J Hosp Pharm; 1972 Mar; 29(3):229-34. PubMed ID: 5028475
    [No Abstract]   [Full Text] [Related]  

  • 7. FDA-USP drug product problem reporting program--an update.
    Wheatley LS
    Hosp Formul; 1979 Mar; 14(3):359-60, 365. PubMed ID: 10316797
    [No Abstract]   [Full Text] [Related]  

  • 8. [Planning and contract directions in the distribution and consumption of drugs].
    Ausborn D
    Pharm Prax; 1969; 4():90-2. PubMed ID: 5792750
    [No Abstract]   [Full Text] [Related]  

  • 9. [Physicians' Union recommends centralization of information on drugs].
    Lakartidningen; 1968 May; 65(21):2162-4. PubMed ID: 5725028
    [No Abstract]   [Full Text] [Related]  

  • 10. [How doctors use and consider the various drug information sources available in Norway. Results from a general enquiry in 1970 and an additional enquiry in 1971].
    Jenssen PG; Lunde PK
    Tidsskr Nor Laegeforen; 1972 Feb; 92(6):407-14. PubMed ID: 5021420
    [No Abstract]   [Full Text] [Related]  

  • 11. The preclinical brochure for clinical investigators.
    Mittelmark A
    J Oral Ther Pharmacol; 1967 Mar; 3(5):387-90. PubMed ID: 6028801
    [No Abstract]   [Full Text] [Related]  

  • 12. Package-stuffer "facts".
    Salter FJ; Cupit GC
    N Engl J Med; 1971 Nov; 285(21):1202-3. PubMed ID: 5096646
    [No Abstract]   [Full Text] [Related]  

  • 13. Michigan regional drug information network. IV. Description and evaluation.
    Pearson RE; Thudium VF; Phillips GL
    Am J Hosp Pharm; 1972 Apr; 29(4):312-20. PubMed ID: 5025261
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pharmaceutical economics and socialist organization science. Drug marketing series. Implication of marketing in the lapse of time in drug studies].
    Alcer G
    Pharm Prax; 1970; 8():169-73. PubMed ID: 5524906
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmaceutical economics and socialist organization science. 25. Processes in drug supply from viewpoint of the theory of supply].
    Seidlein HJ
    Pharm Prax; 1970; 8():181-2. PubMed ID: 5524908
    [No Abstract]   [Full Text] [Related]  

  • 16. [Ascending curves of new products: an instrument of marketing].
    Barocco V
    Boll Chim Farm; 1976 Jul; 115(7):529-37. PubMed ID: 1016609
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug consumption and drug compensation].
    Asbrink A
    Nord Med; 1970 Sep; 84(39):1249. PubMed ID: 5469311
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dangerous drugs and alcohol in traffic].
    Dalgaard JB
    Ugeskr Laeger; 1974 Jun; 136(23):1263-4. PubMed ID: 4832549
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the function of pharmacy and on some problems of cooperation in the system of material economy of Health Department especially between pharmacy and drug industry].
    Dittes W
    Pharm Prax; 1969; 4():93-5. PubMed ID: 5792751
    [No Abstract]   [Full Text] [Related]  

  • 20. Surviving the blockbuster syndrome.
    Service RF
    Science; 2004 Mar; 303(5665):1796-9. PubMed ID: 15031490
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.